Navigation Links
First Conclusive Evidence Linking Oral Bacteria To Premature Babies

It is generally accepted that periodontal disease is not a desirable condition in pregnancy and can result in premature babies, but for the first time researchers from Case Western Reserve University //School of Dental Medicine and the Department of Obstetrics and Gynecology at MetroHealth Medical Center in Cleveland have provided conclusive proof for the same.

Their report, titles, "Transmission of an Uncultivated Bergeyella Strain from the Oral Cavity to the Amniotic Fluid in a Case of Preterm Birth" is published in the Journal of Clinical Microbiology online article. Yiping Han, the lead researcher and a Case microbiologist in the Department of Biological Sciences at the Case School of Dental Medicine has been working on this study for the past three years. It was found that a 37-year-old lady who gave birth to a 24-week baby had oral bacteria in her amniotic fluid. The Bergeyella bacteria was found in the amniotic fluid using new DNA finger-printing techniques. The mother did not have periodontal disease. "If periodontal disease is not present, then this raises more questions about how the bacteria got into the amniotic fluid," said Han. Akihiko Ikegami, Nabil Bissada and Raymond Redline from Case and Graham Ashmead and Melissa Herbst from the Department of Obstetrics at Case School of Medicine and MetroHealth Medical Center assisted Han in this investigation.

Contact:

Susan Griffith
susan.griffith@case.edu
216-368-1004
Case Western Reserve University
Source: Eurekalert

'"/>




Page: 1

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. First human clone is near
4. First Artificial Heart patient has Major setback
5. First head-to-head trials of once weekly Fosamax and Actonel therapies
6. WHO Declares Vietnam First Country to Control SARS
7. Russia Reports First SARS Case
8. Hope for First New Melanoma Treatment in Decades
9. First global SARS meet opens
10. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
11. Hyderabad To Have Asia’s First Catheter Making Uni
Post Your Comments:
(Date:7/8/2008)... DETROIT, July 8 /PRNewswire-USNewswire/ -- The... it has signed an agreement with Meadowbrook C,Man...Meadowbrook Medical,Center, located in Novi, Michi...ll allow Karmanos to expand its outreach to cancer... as well as provide access to radiation,oncology, ...
(Date:7/8/2008)... Recently identified genetic markers, called sing...iated with a small but statistically significant i... to substantially improve the accuracy of existing...dividual,s risk, according to a study in the July ...cer Institute . , Risk prediction models provide...
(Date:7/8/2008)... PITTSBURGHUniversity of Pittsburgh-led researche...ongenital circulatory problemsaortic arch deformit... humans, as reported in the June 15 edition of De...sistant professor of biological sciences in Pitt,s... first complete published description of how aorti...
(Date:7/8/2008)...Study says Medicare Modernization Act yet to show ... , TUESDAY, July 8 (HealthDay News) -- Chemothera...ederal legislation that has reduced reimbursements...nds. , Critics feared the passing of the Medica...more difficult, but investigators from the Duke Cl...
Breaking Medicine News(10 mins):Health News:Karmanos Cancer Center Partners With Meadowbrook to Expand Outreach and Access for Cancer Services 2Health News:Single-nucleotide polymorphisms do not substantially improve risk prediction for breast cancer 2Health News:Pitt-led research provides insight into development of congenital circulatory defects 2Health News:Cancer Care Unaffected by Doctor Reimbursement Changes 2
...e affected more than 50% of the patients with skin... are also not following the norms to// prescribe t...re the infection before prescribing antibiotics bu...h strain causing the infection will be susceptible...
... Ruby had never been on a date, much less had a bo... any type of intimacy, even with family// and life...t The Methodist Hospital Weight Management Center ...timacy is not sex. Intimacy is sensuality, sexuali...
...e efficacy of smoke alarms has suggested that high... elderly. The research conducted on 42// adults, b...quency signal showed better results than a complet...oke alarms use. Data from the National Fire Prot...
...ting berries may be good for mental health althoug... these applications towards humans.// Researchers...versity have studied 60 young male rats, after spl...ls of the study have been reported in the online e...
Other Medicine News:
(Date:7/3/2008)...RUNSWICK, N.J., July 3 /- S...ny") (Amex: SNT ) announced today,that it has con...") to,supply the plasmid portion of the Company,s ...ne and siRNA against Factor 5A., Senesco has prev...ts,using its combination siRNA and plasmid against...
(Date:7/2/2008)...cified Primary Efficacy Endpoint Met in Stage 1 of... -, - 100% of Evaluable Patients to Date Continu...ponse or Stable Disease -, TUSTIN, Calif., July 2...ls, Inc. (Nasdaq: PPHM ) today reported that its ...e-specified Stage 1 primary endpoint,in its ongoin...
(Date:7/1/2008)...DELPHIA, July 1 /PRNewswire-USNewswire/ -- Researc... role in some varieties of adult,rheumatoid arthri...ritis.,The researchers say the responsible gene ma...litating disease., Researchers at The Children,s ...een the gene region and juvenile idiopathic arthri...
(Date:7/1/2008)...NKI, July 1 /- The emergence of multi...ated the use of polymyxins as the agents,of last r...hern Antibiotics,Ltd, a Finnish biotech company, h...early preclinical studies show signs of lower neph...ve charges only, while polymyxin B,and colistin ha...
Breaking Medicine Technology:Senesco Chooses VGXI to Produce Factor 5A Plasmid 2Senesco Chooses VGXI to Produce Factor 5A Plasmid 3Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 2Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 3Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 4Pediatric Researchers Find Possible 'Master Switch' Gene in Juvenile Arthritis 2Pediatric Researchers Find Possible 'Master Switch' Gene in Juvenile Arthritis 3Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity 2Edge Dynamics New Dashboard Unlocks Value of Channel Data Enterprise wide 8193 1Edge Dynamics New Dashboard Unlocks Value of Channel Data Enterprise wide 8193 2Edge Dynamics New Dashboard Unlocks Value of Channel Data Enterprise wide 8193 3Edge Dynamics New Dashboard Unlocks Value of Channel Data Enterprise wide 8193 4Naviscans PEM Flex 28TM 29 Scanner Shows Promising New Data in Breast Cancer Management 8191 1Naviscans PEM Flex 28TM 29 Scanner Shows Promising New Data in Breast Cancer Management 8191 2SmartOps Enterprise Inventory Optimization Software Licensed by Wyeth 8189 1PartsSource Named 2007 Weatherhead 100 Award Winner 8187 1
..., U.K. 2nd July 2007 - CeNeS Pharmaceuticals (AIM:...d biopharmaceutical,company today announced that a... supports the hypothesis that a,catechol-O-methylt... would be a useful agent to address profound cogni...r. CeNeS has an,ongoing discovery programme to dev...
...uctions Observed at Eight Weeks Sustained up to 12...TH SAN FRANCISCO, Calif., July 02, 2007,/PRNewswir...iminary,longer-term, follow-up results from a Phas...TM) (formerly 4975) in patients with,moderate-to-s...ial,reductions in pain that persisted for up to 12...
Other Medicine Technology:Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 2Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 3Major New Review Supports the Broader Potential of CeNeS COMT,Inhibitor Discovery Programme 4Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 2Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 3Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 4Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain,Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the,Knee 5
... and best value in high performance electronic pip...htweight design reduce hand fatigue and strain , S...or , Color coding for easy volume identification ,... use Hamilton AdvanTip Low Retention and AdvanTip ...
The Finnpipette BioControl multichannel has the same innovative features as the single channel model.The same universal handle fits all seven multichannel and five single channel tip cone modules. Bo
...Pipette is ideal for all liquid handling applicati... ergonomically-placed operating buttons, and vario...sing, reverse pipetting and diluting make this a l...ctions of a manual pipette without any adverse eff...
...lleled Comfort Pick one of our pipettors up and u...ejector positionsright where they should beeven if...e ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand Start dis...
Medicine Products: